Shows worsening food allergy symptoms in neonatal mice on amino acid diet, suggesting GCDCA supplementation may help.
Amino acid–based formulas (AAFs) are increasingly consumed in infants with food allergy (FA), while the effects of their long-term consumption on FA remain poorly known. This study investigated the effects of the long-term consumption of AAFs on FA by subjecting neonatal mice to an amino acid–based diet (AAD). Long-term consumption of AAD exacerbated allergic symptoms, Th2 responses, and mast cell activation and concurrently suppressed the differentiation of CD103 + DCs and Tregs in the MLN. Furthermore, integrated metabolomics and metagenomics analysis revealed that AAD induced intestinal microbiota dysbiosis and altered the systemic metabolome, characterized by a marked depletion of Bacteroides and glycochenodeoxycholic acid (GCDCA). Critically, oral supplementation with GCDCA effectively attenuated the FA response in AAD-fed mice. In summary, our findings suggest that long-term consumption of AAD aggravates FA via GCDCA depletion, which highlights the necessity to avoid the excessive use of AAFs and positions GCDCA supplementation as a promising therapeutic strategy for FA.
No takes yet. Share an insight, caveat, or question.
Shi et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: